Her scientific interests lie mostly in Huntington's disease, Psychiatry, Disease, Cognition and Degenerative disease. Her studies deal with areas such as Rating scale, Trinucleotide repeat expansion, Predictive value of tests, Gene mutation and Pediatrics as well as Huntington's disease. The Psychiatry study combines topics in areas such as Dementia and Clinical psychology.
Her Disease research incorporates elements of Neuroscience, Depression, Clinical trial and Genetic testing. Her Cognition study integrates concerns from other disciplines, such as Alzheimer's disease, Neuropathology and Cognitive psychology. Her Degenerative disease research incorporates themes from Basal ganglia and Atrophy.
Jane S. Paulsen mainly investigates Disease, Huntington's disease, Psychiatry, Cognition and Clinical psychology. Her biological study spans a wide range of topics, including Clinical trial, Pediatrics, Genetic testing and Rating scale. Her Huntington's disease study combines topics in areas such as Audiology, Trinucleotide repeat expansion, Basal ganglia, Neuroscience and Degenerative disease.
Her work in Psychiatry addresses issues such as Dementia, which are connected to fields such as Alzheimer's disease. Her work carried out in the field of Cognition brings together such families of science as Developmental psychology and Prodrome. Her Clinical psychology study which covers Neuropsychological test that intersects with Psychometrics.
Her primary scientific interests are in Disease, Huntington's disease, Cognition, Clinical psychology and Internal medicine. Her Disease research includes elements of White matter, Clinical trial, Rating scale, Quality of life and Psychiatry. She has researched Huntington's disease in several fields, including Striatum, Trinucleotide repeat expansion, Neuroscience, Putamen and Apathy.
Her research integrates issues of Quality of life and Audiology in her study of Cognition. Jane S. Paulsen combines subjects such as Reliability and Anxiety with her study of Clinical psychology. Jane S. Paulsen has included themes like Physical therapy, Sample size determination and Oncology in her Internal medicine study.
The scientist’s investigation covers issues in Disease, Huntington's disease, Putamen, Internal medicine and Cognition. Her Disease research is multidisciplinary, incorporating elements of Diffusion MRI, Pediatrics, Patient population and Quality of life. Her Huntington's disease study combines topics from a wide range of disciplines, such as Resting state fMRI, Neuroscience, Audiology and Trinucleotide repeat expansion.
Her Putamen research incorporates elements of White matter, Genetics, Allele and Pathology. Her Cognition research is multidisciplinary, relying on both Dementia and Clinical psychology. The concepts of her Quality of Life Research study are interwoven with issues in Social determinants of health and Psychiatry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Unified huntington’s disease rating scale: Reliability and consistency
Karl Kieburtz;John B. Penney;Peter Corno;Neal Ranen.
Neurology (2001)
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset
Nancy S. Wexler;Judith Lorimer;Julie Porter;Fidela Gomez.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Detection of Huntington’s disease decades before diagnosis: The Predict HD study
Jane Paulsen;Douglas R Langbehn;Julie C Stout;Elizabeth H Aylward.
Journal of Neurology, Neurosurgery, and Psychiatry (2008)
Apathy Is Not Depression
Morgan L. Levy;Jeffrey L. Cummings;Lynn A. Fairbanks;Donna Masterman.
Journal of Neuropsychiatry and Clinical Neurosciences (1998)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A Ross;Elizabeth Hoppes Aylward;Edward J Wild;Douglas R Langbehn.
Nature Reviews Neurology (2014)
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
Douglas R. Langbehn;Ryan R. Brinkman;Daniel Falush;Jane S. Paulsen.
Clinical Genetics (2004)
Is it possible to be schizophrenic yet neuropsychologically normal
Barton W. Palmer;Robert K. Heaton;Jane S. Paulsen;Julie Kuck.
Neuropsychology (journal) (1997)
Deep learning for neuroimaging: A validation study
Sergey M. Plis;Devon R. Hjelm;Ruslan Salakhutdinov;Elena A. Allen;Elena A. Allen.
Frontiers in Neuroscience (2014)
Generalized Cognitive Deficits in Schizophrenia: A Study of First-Episode Patients
Somaia Mohamed;Jane S. Paulsen;Daniel O'Leary;Stephen Arndt.
Archives of General Psychiatry (1999)
Neuropsychological Deficits in Schizophrenics: Relationship to Age, Chronicity, and Dementia
Robert Heaton;Jane S. Paulsen;Lou Ann McAdams;Julie Kuck.
Archives of General Psychiatry (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Iowa
University of Iowa
University of Utah
Monash University
Seattle Children's Hospital
Johns Hopkins University School of Medicine
University of California, San Diego
University of Michigan–Ann Arbor
University of Rochester Medical Center
University of British Columbia
Panasonic (Japan)
Tsinghua University
Centre national de la recherche scientifique, CNRS
Stanford University
Washington University in St. Louis
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev
Emory University
Washington University in St. Louis
Harvard University
University of Oslo
Brunel University London
University of Florence
St Bartholomew's Hospital
University of Strasbourg
MIT